Description

The global emerging medical device technologies market is poised to grow by US$ 103.6 billion during 2022-2028, progressing at a CAGR of 12.3% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for emerging medical device technologies. The global emerging medical device technologies market is segmented on the basis of segment, and region. By segment, the global emerging medical device technologies market has been segmented into cardiovascular, diabetes, drug delivery, gastrointestinal endoscopy, IVD (vitro diagnostic), neurology, ophthal, orthopedic, wound care. In 2021, the cardiovascular segment made up the largest share of revenue generated by the emerging medical device technologies market. Geographically, the global emerging medical device technologies market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW). North America was the largest contributor to the global emerging medical device technologies market in 2021.

The cardiovascular devices market is further segmented into electrophysiology (EP), endovascular aortic repair (EVAR), heart failure devices, interventional cardiology (IC), peripheral vascular devices (PVD), subcutaneous ICD, and transcatheter heart valve therapy. Among these, the heart failure devices segment was accounted for the highest revenue generator in 2021. Furthermore, the IVD devices market has been categorized into advanced cancer molecular diagnostics, companion diagnostics, and professional POC. The professional POC segment captured the largest share of the market in 2021 and is expected to maintain its dominance during the forecast period. The orthopedic devices market is further divided into extremity joint reconstruction, and soft tissue fixation and repair. According to the research, the soft tissue fixation and repair segment had the largest share in the global emerging medical device technologies market.

The global emerging medical device technologies market is highly competitive. The prominent players operating in the global emerging medical device technologies market include 3M Company, Abbott Laboratories, Agilent Technologies Inc., Allergan Inc., Biolase Inc., BioMerieux S.A., Boston Scientific Corp., Cardinal Health Inc., Cook Group, Cordis Corporation, Edwards Lifesciences Corporation, GE Healthcare, Illumina Inc., Karl Storz SE & Co. KG, Medtronic plc, Mindray Medical International Limited, Myriad Genetics Inc., Nidek Co. Ltd., Novartis International AG, Roche Holding AG, Shimadzu Corp., Siemens Healthineers AG, Smith & Nephew plc, Stryker Corporation, Terumo Corp., Zimmer Biomet Holdings Inc. Competitive landscape gives a description of the competitive nature of the global emerging medical device technologies market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the emerging medical device technologies market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Segment: cardiovascular, diabetes, drug delivery, gastrointestinal endoscopy, IVD (vitro diagnostic), neurology, ophthal, orthopedic, wound care
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028
Company mentioned: 3M Company, Abbott Laboratories, Agilent Technologies Inc., Allergan Inc., Biolase Inc., BioMerieux S.A., Boston Scientific Corp., Cardinal Health Inc., Cook Group, Cordis Corporation, Edwards Lifesciences Corporation, GE Healthcare, Illumina Inc., Karl Storz SE & Co. KG, Medtronic plc, Mindray Medical International Limited, Myriad Genetics Inc., Nidek Co. Ltd., Novartis International AG, Roche Holding AG, Shimadzu Corp., Siemens Healthineers AG, Smith & Nephew plc, Stryker Corporation, Terumo Corp., Zimmer Biomet Holdings Inc.

Key Benefits for Stakeholders

– Get a comprehensive picture of the global emerging medical device technologies market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Emerging medical device technologies market overview
Part 3. Market breakdown by segment
– Cardiovascular
– Diabetes
– Drug delivery
– Gastrointestinal endoscopy
– IVD (vitro diagnostic)
– Neurology
– Ophthal
– Orthopedic
– Wound care
Part 4. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 5. Key companies
– 3M Company
– Abbott Laboratories
– Agilent Technologies, Inc.
– Allergan Inc.
– Biolase, Inc.
– BioMerieux S.A.
– Boston Scientific Corp.
– Cardinal Health, Inc.
– Cook Group
– Cordis Corporation
– Edwards Lifesciences Corporation
– GE Healthcare
– Illumina, Inc.
– Karl Storz SE & Co. KG
– Medtronic plc
– Mindray Medical International Limited
– Myriad Genetics, Inc.
– Nidek Co., Ltd.
– Novartis International AG
– Roche Holding AG
– Shimadzu Corp.
– Siemens Healthineers AG
– Smith & Nephew plc
– Stryker Corporation
– Terumo Corp.
– Zimmer Biomet Holdings, Inc.
About StrategyHelix
Disclaimer